Prostate cancer is the most common non-skin cancer in the United States, and the second leading cause of cancer deaths in men, after lung cancer. One in six men will be diagnosed with prostate cancer in his lifetime. Currently there are two screening procedures used by physicians on men to gauge the general health of their prostate gland; one is usually performed beginning at age forty and the other is usually performed when a man turns fifty. My research is on the screening procedures and diagnosis of prostate cancer on men between the ages of 40-50
Screening for prostate cancer is technically feasible. Recent advances in diagnostic strategies have...
In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to upda...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...
Prostate cancer is the most common non-skin cancer in the United States, and the second leading caus...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
Background: Prostate cancer is a risk for men aged 40+ even if it is rarely seen among men under the...
Prostate cancer is a potential men’s health problem. The prevalence of prostate cancer continues to ...
In American men, prostate cancer is the most common cancer and the second leading cause of cancer de...
The aim of this study was to confirm the role of screening by determining the percentage of clinical...
textabstractProstate cancer is nowadays the most common non-cutaneous cancer in men in the Western w...
The natural history of prostate cancer is remarkably heterogeneous and, at this time, not completely...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Evaluating for and management of early prostate cancer is just one of the most difficult and controv...
textabstractAlthough the concept of early detection of cancer sounds intuitively logical it is not...
IntroductionBetween November 2000 and January 2001 screening for prostate cancer has been conducted ...
Screening for prostate cancer is technically feasible. Recent advances in diagnostic strategies have...
In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to upda...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...
Prostate cancer is the most common non-skin cancer in the United States, and the second leading caus...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
Background: Prostate cancer is a risk for men aged 40+ even if it is rarely seen among men under the...
Prostate cancer is a potential men’s health problem. The prevalence of prostate cancer continues to ...
In American men, prostate cancer is the most common cancer and the second leading cause of cancer de...
The aim of this study was to confirm the role of screening by determining the percentage of clinical...
textabstractProstate cancer is nowadays the most common non-cutaneous cancer in men in the Western w...
The natural history of prostate cancer is remarkably heterogeneous and, at this time, not completely...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Evaluating for and management of early prostate cancer is just one of the most difficult and controv...
textabstractAlthough the concept of early detection of cancer sounds intuitively logical it is not...
IntroductionBetween November 2000 and January 2001 screening for prostate cancer has been conducted ...
Screening for prostate cancer is technically feasible. Recent advances in diagnostic strategies have...
In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to upda...
Objective. We aimed to evaluate the presenting features and treatment outcome of prostate cancer in ...